Root Financial Partners
ANTX icon

Root Financial Partners’s AN2 Therapeutics ANTX Stock Holding History

Root Financial Partners’s Portfolio ANTX Stock Details ANTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$128 Buy
+24
New +$127 ﹤0.01% 3604

Other funds holding ANTX

Sterling Capital Management
Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return
SBI Securities
SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
Fortitude Family Office
Fortitude Family Office Scottsdale, Arizona $586M AUM 20.58% 1-Year Est. Return

Root Financial Partners's ANTX Position: Q3 2026 in Review

Root Financial Partners opened a new position in AN2 Therapeutics (ANTX) in Q3 2026: 24 shares worth $128. The stake represents ﹤0.01% of the portfolio and ranks #3604 among its holdings.

5 funds tracked by Wall St. Rank hold ANTX as of Q3 2026.

  • Root Financial Partners held 24 shares of AN2 Therapeutics worth $128 as of Q3 2026.
  • AN2 Therapeutics was a new Root Financial Partners position in Q3 2026.
  • AN2 Therapeutics made up ﹤0.01% of Root Financial Partners's portfolio in Q3 2026, its #3604 holding.
  • 5 funds tracked by Wall St. Rank held AN2 Therapeutics as of Q3 2026.

Based on Root Financial Partners's 13F filing for Q3 2026, filed 21 Oct 2026.